EG BIOMED US INC.

 

Area: Country Pavilion

Booth No: M709

Website: https://eg-bio.com/ ; https://www.eg-biomed-us.com/

 

Exhibitor Profile

 

EG BIOMED US INC. operates a CLIA and CAP certified clinical laboratory in Washington State and specializes in liquid biopsy and precision medicine technologies. Its core platform focuses on DNA methylation-based blood testing for early cancer detection, treatment monitoring, and recurrence surveillance. Developed non-invasive multi-cancer screening solutions with over 90% sensitivity and specificity. Technologies are protected by patents in 29 countries and have been presented at AACR and ASCO.

 

Brands

 

OkaiDx™ Cancer Detection Blood Test (Pancreatic Cancer, Gastrointestinal Cancer, Colorectal Cancer, and Breast Cancer), DNA Methylation Aging Test

 

Video

 

• 

  【Revolutionizing Gastrointestinal Health】The OkaiDx™ Cancer Detection Blood Test

 

 

Exhibit Products

 

• 

  DNA Methylation Aging Test

• 

  OkaiDx™ Breast Cancer Monitoring Blood Test

• 

  OkaiDx™ Colorectal Cancer Detection Blood Test

• 

  OkaiDx™ Gastrointestinal Cancer Detection Blood Test

• 

  OkaiDx™ Pancreatic Cancer Detection Blood Test

 

Exhibitor Press Release

 

• Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser 2026-06-15
• Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science 2026-06-15
• EG BioMed U.S. CLIA/CAP-Certified Laboratory Opens Partnership Opportunities 2026-06-15

 

 

 

back